210 related articles for article (PubMed ID: 36966453)
1. A Narrative Review of Acthar Gel for the Treatment of Myositis.
Chandra T; Aggarwal R
Rheumatol Ther; 2023 Jun; 10(3):523-537. PubMed ID: 36966453
[TBL] [Abstract][Full Text] [Related]
2. Acthar
Kaplan J; Askanase A; Chu D; Abdellatif A; Basu D; Mirsaeidi M
Clin Drug Investig; 2023 Oct; 43(10):739-761. PubMed ID: 37792273
[TBL] [Abstract][Full Text] [Related]
3. Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review.
Mirsaeidi M; Baughman RP
Pulm Ther; 2022 Mar; 8(1):43-55. PubMed ID: 35113366
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications.
Philbin M; Niewoehner J; Wan GJ
Adv Ther; 2017 Aug; 34(8):1775-1790. PubMed ID: 28660550
[TBL] [Abstract][Full Text] [Related]
5. Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies.
Patel A; Seely G; Aggarwal R
Case Rep Rheumatol; 2016; 2016():9068061. PubMed ID: 27642533
[TBL] [Abstract][Full Text] [Related]
6. Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence.
Wan GJ; Niewoehner J; Hayes K
Clinicoecon Outcomes Res; 2023; 15():499-512. PubMed ID: 37397803
[TBL] [Abstract][Full Text] [Related]
7. A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus.
Askanase AD; Furie RA
Adv Ther; 2022 Jul; 39(7):3088-3103. PubMed ID: 35641860
[TBL] [Abstract][Full Text] [Related]
8. Follow-up results of myositis patients treated with H. P. Acthar gel.
Saygin D; Oddis CV; Marder G; Moghadam-Kia S; Nandkumar P; Neiman N; Dzanko S; Koontz D; Aggarwal R
Rheumatology (Oxford); 2020 Oct; 59(10):2976-2981. PubMed ID: 32160301
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis.
Aggarwal R; Marder G; Koontz DC; Nandkumar P; Qi Z; Oddis CV
Ann Rheum Dis; 2018 May; 77(5):720-727. PubMed ID: 29237618
[TBL] [Abstract][Full Text] [Related]
10. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ
Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646
[TBL] [Abstract][Full Text] [Related]
11. Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection.
Hayes K; Panaccio MP; Houston P; Niewoehner J; Fahim M; Wan GJ; Dhillon B
Open Access Rheumatol; 2021; 13():315-323. PubMed ID: 34703332
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms.
Duchowny MS; Chopra I; Niewoehner J; Wan GJ; Devine B
J Health Econ Outcomes Res; 2021 Jan; 8(1):1-9. PubMed ID: 33521161
[No Abstract] [Full Text] [Related]
13. Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids.
Wynn D; Goldstick L; Bauer W; Zhao E; Tarau E; Cohen JA; Robertson D; Miller A
CNS Neurosci Ther; 2022 Mar; 28(3):364-371. PubMed ID: 34984839
[TBL] [Abstract][Full Text] [Related]
14. Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial.
Askanase AD; Zhao E; Zhu J; Connolly-Strong E; Furie RA
Lupus Sci Med; 2020; 7(1):e000383. PubMed ID: 32399253
[TBL] [Abstract][Full Text] [Related]
15. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
[TBL] [Abstract][Full Text] [Related]
16. Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis.
Busch H; Wan GJ; Niewoehner J; Houston P; Su Y; Clinton C; Panaccio MP
Drugs Context; 2022; 11():. PubMed ID: 35382109
[TBL] [Abstract][Full Text] [Related]
17. Treatment with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Dermatomyositis/Polymyositis.
Ho-Mahler N; Turner B; Eaddy M; Hanke ML; Nelson WW
Open Access Rheumatol; 2020; 12():21-28. PubMed ID: 32110122
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis.
Zhen C; Hou Y; Zhao B; Ma X; Dai T; Yan C
Front Immunol; 2022; 13():1051609. PubMed ID: 36578492
[TBL] [Abstract][Full Text] [Related]
19. Repository Corticotropin Injection (Acthar
Wirta D; McLaurin E; Ousler G; Liu J; Kacmaz RO; Grieco J
Ophthalmol Ther; 2021 Dec; 10(4):1077-1092. PubMed ID: 34669183
[TBL] [Abstract][Full Text] [Related]
20. Polymyositis and dermatomyositis: Disease spectrum and classification.
Raychaudhuri SP; Mitra A
Indian J Dermatol; 2012 Sep; 57(5):366-70. PubMed ID: 23112356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]